Total Payments
$36,157
2024 Payments
$12,092
Companies
37
Transactions
652
Medicare Patients
3,788
Medicare Billing
$229,056
Payment Breakdown by Category
Consulting$20,300 (56.1%)
Food & Beverage$11,365 (31.4%)
Travel$2,990 (8.3%)
Other$875.00 (2.4%)
Education$626.68 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,300 | 4 | 56.1% |
| Food and Beverage | $11,365 | 620 | 31.4% |
| Travel and Lodging | $2,990 | 13 | 8.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $875.00 | 1 | 2.4% |
| Education | $626.68 | 14 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $24,889 | 175 | $0 (2024) |
| ABBVIE INC. | $2,519 | 89 | $0 (2024) |
| EPI Health, LLC | $1,514 | 2 | $0 (2022) |
| Dermavant Sciences, Inc. | $982.06 | 47 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $867.26 | 69 | $0 (2024) |
| GENZYME CORPORATION | $835.25 | 41 | $0 (2024) |
| Lilly USA, LLC | $608.85 | 27 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $457.03 | 25 | $0 (2024) |
| UCB, Inc. | $391.59 | 21 | $0 (2024) |
| PFIZER INC. | $316.63 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,092 | 241 | Janssen Biotech, Inc. ($8,916) |
| 2023 | $10,203 | 140 | Janssen Biotech, Inc. ($8,704) |
| 2022 | $10,067 | 136 | Janssen Biotech, Inc. ($6,969) |
| 2021 | $847.31 | 44 | AbbVie Inc. ($167.58) |
| 2019 | $312.75 | 8 | Janssen Biotech, Inc. ($117.17) |
| 2018 | $457.48 | 23 | Lilly USA, LLC ($144.89) |
| 2017 | $2,178 | 60 | AbbVie, Inc. ($1,280) |
All Payment Transactions
652 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.49 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/27/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Immunology | ||||||
| 11/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: DERMATOLOGY | ||||||
| 11/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $6,600.00 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | Cash or cash equivalent | $32.20 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | Cash or cash equivalent | $17.42 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $51.11 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 497 | 766 | $83,864 | $35,599 |
| 2022 | 11 | 688 | 1,351 | $128,970 | $62,332 |
| 2021 | 13 | 1,042 | 1,806 | $156,465 | $54,735 |
| 2020 | 17 | 1,561 | 2,574 | $247,906 | $76,390 |
Total Patients
3,788
Total Services
6,497
Medicare Billing
$229,056
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 100 | $17,995 | $8,318 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 93 | $10,901 | $5,495 | 50.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 62 | 70 | $11,899 | $4,759 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $9,982 | $4,279 | 42.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 57 | 62 | $10,554 | $3,428 | 32.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $6,916 | $3,177 | 45.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 75 | 83 | $8,725 | $2,826 | 32.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 19 | 19 | $4,427 | $2,146 | 48.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 55 | 263 | $2,465 | $1,168 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 148 | $24,955 | $13,406 | 53.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 128 | 170 | $19,772 | $11,675 | 59.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 91 | 122 | $21,228 | $10,041 | 47.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 34 | 52 | $11,856 | $6,642 | 56.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 72 | 92 | $15,180 | $5,781 | 38.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 98 | 125 | $13,000 | $4,390 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $10,360 | $4,195 | 40.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 37 | 37 | $6,262 | $2,739 | 43.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 72 | 511 | $4,599 | $2,547 | 55.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 16 | 22 | $1,278 | $896.96 | 70.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 32 | $480.00 | $18.39 | 3.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 262 | 323 | $25,631 | $15,132 | 59.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 144 | $18,050 | $10,461 | 58.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 136 | 161 | $28,734 | $8,386 | 29.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 167 | 196 | $25,640 | $5,319 | 20.7% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 56 | 66 | $20,070 | $4,710 | 23.5% |
About Dr. Kathleen Viola, MD
Dr. Kathleen Viola, MD is a Dermatology healthcare provider based in Sparks Glencoe, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2012. The National Provider Identifier (NPI) number assigned to this provider is 1083971436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathleen Viola, MD has received a total of $36,157 in payments from pharmaceutical and medical device companies, with $12,092 received in 2024. These payments were reported across 652 transactions from 37 companies. The most common payment nature is "Consulting Fee" ($20,300).
As a Medicare-enrolled provider, Viola has provided services to 3,788 Medicare beneficiaries, totaling 6,497 services with total Medicare billing of $229,056. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Sparks Glencoe, MD
- Active Since 04/23/2012
- Last Updated 06/05/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1083971436
Products in Payments
- TREMFYA (Drug) $24,630
- WYNZORA (Drug) $1,500
- DUPIXENT (Biological) $1,137
- VTAMA (Drug) $982.06
- Sotyktu (Drug) $846.04
- TALTZ (Drug) $608.85
- SKYRIZI (Biological) $576.77
- RINVOQ (Biological) $455.39
- Humira (Biological) $395.85
- Otezla (Drug) $288.44
- EUCRISA (Drug) $285.60
- Cimzia (Drug) $228.75
- Enbrel (Biological) $211.36
- ADBRY (Biological) $204.89
- COSENTYX (Biological) $189.98
- Bimzelx (Biological) $162.84
- OPZELURA (Drug) $147.97
- REMICADE (Biological) $145.43
- Winlevi (Drug) $135.09
- KYBELLA (Biological) $126.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.